Targeting GLI proteins in human cancer by small molecules
US9370521B2 · kind B2 · utility
2Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2012 |
| Grant date | Jun 21, 2016 |
| Priority date | — |
| Expiry date | Oct 3, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions, pharmaceutical preparations and methods for the diagnosis and treatment of cancers expressing a GLI polypeptide. The disclosed compositions and pharmaceutical preparations may comprise one or more pyrazolyl-containing compounds, or an analog or derivative thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.